Trilaciclib
Product Specifications
CAS Number
1374743-00-6
Target
Cell Cycle Arrest|||CDK
Related Pathways
Cell Cycle/Checkpoint
Purity
0.9962
Bioactivity
Trilaciclib is a short-acting, orally effective CDK4/6 inhibitor with IC?? values of 1 nM and 4 nM respectively. It transiently and reversibly induces G1 cell cycle arrest, mitigates chemotherapy-induced myelosuppression, and enhances antitumour immunity, making it applicable across multiple cancers.
Smiles
CN1CCN(CC1)c1ccc(Nc2ncc3cc4C(=O)NCC5(CCCCC5)n4c3n2)nc1
Molecular Formula
C24H30N8O
Molecular Weight
446.55
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS629821-01 0.2 mL
TSC2, phosphorylated (Ser664) (Tuberin, Tuberous Sclerosis 2 Protein, TSC4)
Ask
View Details 
MBS629821-02 5x 0.2 mL
TSC2, phosphorylated (Ser664) (Tuberin, Tuberous Sclerosis 2 Protein, TSC4)
Ask
View Details MBS1015805-01 0.02 mg (E-Coli)
Recombinant Isophysis tasmanica Ribulose bisphosphate carboxylase large chain (rbcL)
Ask
View Details MBS1015805-02 0.02 mg (Yeast)
Recombinant Isophysis tasmanica Ribulose bisphosphate carboxylase large chain (rbcL)
Ask
View Details MBS1015805-03 0.1 mg (E-Coli)
Recombinant Isophysis tasmanica Ribulose bisphosphate carboxylase large chain (rbcL)
Ask
View Details